Is pharmacology getting you down? Is the list of drugs or medications you must learn daunting? Are the names obscure and obtuse?To learn medications you need to learn their names. If the names make no sense, looking as if someone dumped scrabble pieces onto the table, then there is no "hook" for you to remember them.The author breaks down the generic name and a trade name, for over 400 medications, showing you where the name came from. This will help give you a hook to learn the medications and will give you some interesting facts about them.The author spent five years compiling this book. He did it to learn medication names while attending paramedic school and nursing school which are two of his six degrees: He has three associates degrees, a bachelors, a masters degree, and a professional degree.The authors says some of the name meanings were easy to find but the majority took research into the medications' researchers, history, discovery, design, synthesis, organic chemistry, patents, developers, or marketers. Finding this information helped to change those mysterious and obtuse names into ones that could be understood and hooked into memory.

Walter Skeat (1835-1912) was one of the greatest investigators of the roots of the English language, and his remarkable scholarship was instrumental in the revival of the great works of early English Literature. His astonishing detective work into the origins and development of the world's most widely used language provides an unsurpassed guide to its flexibility and richness.

Reprint of the original, first published in 1859.

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.